跳至主要内容
临床试验/NCT02254642
NCT02254642终止不适用

Protective Effects of Ischemic Preconditioning on Cardiac, Renal, Pulmonary and Muscular Functions After Aortic Clamping

University Hospital, Strasbourg, France4 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2018年11月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
59
试验地点
4
主要终点
Myocardial damage measured by troponin level > 0.4 microgr/L (day 1)

研究概览

简要总结

Open surgery for aneurysmal aortic disease can lead to cardiac, renal, pulmonary or muscular complications, essentially due to the aortic clamping. Ischemic preconditioning can be useful in order to decrease these complications. The investigators would like to use an ischemic preconditioning protocol during open surgery of aortic aneurysm in order to decrease these complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with an aortic aneurysm requiring open surgery (with no possibility of endovascular surgery)
  • •Patients who received clear information, with signed consent
  • •Patients 18 to 85 years

排除标准

  • •Patients under guardianship
  • •No possibility to give the patients clear information (comprehension difficulties, emergency surgery)
  • •Pregnancy, lactation
  • •Hemodialysis

研究组 & 干预措施

Ischemic preconditioning arm

Experimental

Patients will have the ischemic preconditioning protocol 1 hour before the aortic clamping.

干预措施: Ischemic preconditioning during aortic clamping (Procedure)

Control patients

Other

Usual surgery assigned to control patients

干预措施: Procedure/Surgery: usual surgery (Procedure)

结局指标

主要结局

Myocardial damage measured by troponin level > 0.4 microgr/L (day 1)

时间窗: Day 1

Myocardial damage measured by Troponin I level \> 0.4 microg/L

次要结局

  • Renal damage(Day 0, day 1, day 3 or day 5.)
  • Muscle weakness(Day 0, day 1, day 3 or day 5)
  • Myocardial damage measured by troponin level > 0.4 microgr/L(Day 0, 3, or 5)

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验